Expression profile of Oct-4 lung cancer-specific marker prior and subsequent to a salirasib treatment regime

por Ao, Xiang, Zhou, Jie, Liang, Hong Ling, Jiang, Ming, Li, Hong Sheng
Publicado 2017

High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer

por Feng, Hui‐Bo, Chen, Yu, Xie, Zhi, Jiang, Jie, Zhong, Yu‐Min, Guo, Wei‐Bang, Yan, Wen‐Qing, Lv, Zhi‐Yi, Lu, Dan‐Xia, Liang, Hong‐Ling, Xu, Fang‐Ping, Yang, Jin‐Ji, Yang, Xue‐Ning, Zhou, Qing, Zhang, Dong‐Kun, Zhang, Zhou, Chuai, Shao‐Kun, Zhang, Heng‐Hui, Wu, Yi‐Long, Zhang, Xu‐Chao
Publicado 2021